PD-L1通过代谢转移促进瘤性病毒感染,抑制I型IFN通路
Jonathan J Hodgins1,2,3, John Abou-Hamad1,4, Colin Edward O'Dwyer1,2,3
1Cancer Therapeutics Program, Ottawa Hospital Research Institute , Ottawa, Canada.
The Journal of experimental medicine
|June 13, 2024
概括
编程死亡配体1 (PD-L1) 具有内在功能,抑制癌细胞I型干扰素反应. 这种抑制增强了型病毒的疗效,提出了新的治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
- 病毒学 病毒学
背景情况:
- 编程死亡连接体1 (PD-L1) 传统上被视为PD-1的惰性连接体.
- 新出现的证据表明PD-L1在免疫和癌细胞内具有细胞内在的功能.
研究的目的:
- 为了研究PD-L1在癌细胞中的内在功能.
- 确定PD-L1参与对I型干扰素 (IFN) 途径的影响.
- 评估PD-L1介导抑制对型病毒疗效的影响.
主要方法:
- 使用细胞连接体和激动性抗体激活PD-L1.
- 在癌细胞中评估I型IFN通路活性.
- 在PD-L1表达癌症模型中对型病毒疗效的体外和体内评估.
- 对来自癌症患者的瘤扩散物的分析,以检测PD-L1表达和瘤性病毒感染性.
- 代谢分析,以确定与PD-L1相关的代谢变化.
主要成果:
- 参与PD-L1强烈抑制癌细胞中的I型干扰素通路.
- 在PD-L1表达的癌细胞中,I型IFN反应受损导致了瘤性病毒疗效的增强.
- PD-L1表达与患有瘤扩散的患者更好的瘤性病毒感染相关.
- PD-L1促进了新陈代谢转向增加糖解和乳酸生产.
- 乳酸盐被确定为I型IFN反应的抑制剂.
结论:
- PD-L1表现出抑制癌细胞I型干扰素反应的内在功能.
- 通过抑制IFN通路,PD-L1介导的代谢重编程有助于免疫逃避.
- 将PD-L1向疗法与瘤性病毒疗法结合起来,具有显著的治疗潜力.
- 这些发现为结合PD-L1抗体和型病毒的临床试验提供了机制性见解和指导.
相关概念视频
Immune Response Against Viral Pathogens
775
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
775
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
The Intrinsic Apoptotic Pathway
6.5K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.5K
Tumor Immunotherapy
511
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
511
Cytotoxic T Cells-mediated Immune Response
889
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
889


